Coca-Cola Bottling Co. Consolidated (COKE):企業の財務・戦略的SWOT分析

◆英語タイトル:Coca-Cola Bottling Co. Consolidated (COKE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4756
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Coca-Cola Bottling Co. Consolidated (COKE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Coca-Cola Bottling Co. Consolidated (CCBCC) is a producer and distributor of non-alcoholic beverages. The company is independent Coca-Cola bottler in the US. CCBCC provides a range of carbonated and non carbonated beverages. Its product portfolio includes energy drinks, bottled water, tea, coffee, water, juices and sports drinks. The company commercializes products through retail stores and other outlets, including food markets, institutional accounts and vending machine outlets. It caters to retail and commercial markets in North Carolina, South Carolina, Alabama, Georgia, Tennessee and Virginia. The company has production, distribution and sales facilities in Southeast region of the US. CCBCC is headquartered in Charlotte, North Carolina, the US.

Coca-Cola Bottling Co. Consolidated Key Recent Developments

Aug 24,2018: David M. Katz named President and COO; Henry W. Flint named Vice Chairman
Aug 23,2018: Coca-Cola Bottling Co Consolidated names Dave Katz as next COO
Aug 08,2018: Coca-Cola Bottling consolidated reports second quarter 2018 results
May 08,2018: Coca-Cola Bottling Consolidated posts Q1 2018 results
Apr 12,2018: Coca-Cola introduces Thums Up Charged sugar-free variant in India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Coca-Cola Bottling Co. Consolidated – Key Facts 5
Coca-Cola Bottling Co. Consolidated – Key Employees 6
Coca-Cola Bottling Co. Consolidated – Key Employee Biographies 7
Coca-Cola Bottling Co. Consolidated – Major Products and Services 8
Coca-Cola Bottling Co. Consolidated – History 9
Coca-Cola Bottling Co. Consolidated – Company Statement 12
Coca-Cola Bottling Co. Consolidated – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Coca-Cola Bottling Co. Consolidated – Business Description 16
Coca-Cola Bottling Co. Consolidated – Corporate Strategy 17
Coca-Cola Bottling Co. Consolidated – SWOT Analysis 20
SWOT Analysis – Overview 20
Coca-Cola Bottling Co. Consolidated – Strengths 20
Coca-Cola Bottling Co. Consolidated – Weaknesses 21
Coca-Cola Bottling Co. Consolidated – Opportunities 22
Coca-Cola Bottling Co. Consolidated – Threats 23
Coca-Cola Bottling Co. Consolidated – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Recent Developments 31
Aug 24, 2018: David M. Katz named President and COO; Henry W. Flint named Vice Chairman 31
Aug 24, 2018: David M. Katz named President and COO; Henry W. Flint named Vice Chairman 32
Aug 08, 2018: Coca-Cola Bottling consolidated reports second quarter 2018 results 33
Apr 12, 2018: Coca-Cola introduces Thums Up Charged sugar-free variant in India 34
Apr 12, 2018: Coca-Cola introduces Thums Up Charged sugar-free variant in India 35
Jan 26, 2018: Coca Cola Bottling Co. Consolidated Announces Repositioning of its Executive Vice Presidents 36
Nov 07, 2017: Coca-Cola Bottling Co. Consolidated reports Q3 2017 results 37
May 09, 2017: Coca‑Cola Bottling Co. Consolidated reports Q1 2017 results 39
Mar 08, 2017: Coca-Cola Bottling Q4 net income increases 40
Section 5 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Coca-Cola Bottling Co. Consolidated, Key Facts 5
Coca-Cola Bottling Co. Consolidated, Key Employees 6
Coca-Cola Bottling Co. Consolidated, Key Employee Biographies 7
Coca-Cola Bottling Co. Consolidated, Major Products and Services 8
Coca-Cola Bottling Co. Consolidated, History 9
Coca-Cola Bottling Co. Consolidated, Other Locations 13
Coca-Cola Bottling Co. Consolidated, Subsidiaries 13
Coca-Cola Bottling Co. Consolidated, Key Competitors 24
Coca-Cola Bottling Co. Consolidated, Ratios based on current share price 25
Coca-Cola Bottling Co. Consolidated, Annual Ratios 26
Coca-Cola Bottling Co. Consolidated, Annual Ratios (Cont...1) 27
Coca-Cola Bottling Co. Consolidated, Annual Ratios (Cont...2) 28
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Coca-Cola Bottling Co. Consolidated, Performance Chart (2013 - 2017) 29
Coca-Cola Bottling Co. Consolidated, Ratio Charts 30

★海外企業調査レポート[Coca-Cola Bottling Co. Consolidated (COKE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • SpectraScience Inc (SCIE)-医療機器分野:企業M&A・提携分析
    Summary SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This s …
  • HealthSouth Corporation:企業のM&A・事業提携・投資動向
    HealthSouth Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HealthSouth Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Radius Health Inc (RDUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Radius Health Inc (Radius Health), formerly NuVios, Inc., is a biopharmaceutical company that develops and commercializes therapeutics for osteoporosis, oncology and endocrine diseases. The company’s product includes abaloparatide injection, which is used for the treatment of postmenopausal …
  • Mitsui O.S.K. Lines Ltd (9104)-石油・ガス分野:企業M&A・提携分析
    Summary Mitsui O.S.K. Lines Ltd (MOL) is a global marine logistic company. It owns and operates dry bulkers, tankers, LNG carriers, containerships, ferries & coastal RoRo ships, cruise ships. The company’s dry bulkers transport dry bulk cargo such as iron ore, coal, grains, wood, wood chips, cement, …
  • Invuity Inc (IVTY)-医療機器分野:企業M&A・提携分析
    Summary Invuity Inc (Invuity) is a medical technology company that offers visualization products for the less invasive surgical procedures. The company offers handhelds, retractors and drop-ins. Its handhelds products include saber frazier and saber yankauer. Invuity offers retractors such as breite …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • HepQuant Llc:製品パイプライン分析
    Summary Hepquant LLC (Hepquant) is a medical device company that provides diagnostic products. The company develops and markets products for measuring liver function. It offers products such as hepquant-stat, hepquant-shunt, and hepquant-flow. Hepquant’s hepquant-STAT is used in screening assay to i …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Washington University in St Louis-製薬・医療分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range o …
  • Polaris Industries Inc.:企業の戦略・SWOT・財務情報
    Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Beximco Pharmaceuticals Ltd (BXPHARMA):企業の財務・戦略的SWOT分析
    Summary Beximco Pharmaceuticals Ltd (Beximco Pharma) is a manufacturer and exporter of generic medicines and active pharmaceutical ingredients (APIs). The company offers products in the therapeutic areas of allergic disorders, analgesics and antipyretic, anti-infectives, cardiovascular, central nerv …
  • Nuclear Decommissioning Authority:企業の戦略的SWOT分析
    Nuclear Decommissioning Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Uni-President Enterprises Corp:企業の戦略・SWOT・財務情報
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • InsuLine Medical Ltd (INSL)-医療機器分野:企業M&A・提携分析
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products include InsuPad and InsuPatch. Its InsuPad is a patch for syringes and insulin pens; and InsuPatch is …
  • General Dynamics Ordnance and Tactical Systems, Inc.:企業の戦略・SWOT・財務情報
    General Dynamics Ordnance and Tactical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Ordnance and Tactical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • InterOil Exploration & Production ASA (IOX):企業の財務・戦略的SWOT分析
    Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, develops and operates oil and natural gas properties, among others. It operates as an active license partner in se …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆